Showing results (391-400 of 493) with videos related to

Sort By:
Pageof 50
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2014
Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAKHashem A Dbouk, Lauren M Weil, G K Sachith Perera, et al.
Multiple Sclerosis and Related Disorders|July 27, 2025
Proximity Extension Assay identifies new targets of grey matter pathology in multiple sclerosisH van der Stok, L Coenen, M Weil, et al.
Science Advances|June 5, 2020
Genomic mapping in outbred mice reveals overlap in genetic susceptibility for HZE ion- and γ-ray-induced tumorsE F Edmondson, D M Gatti, F A Ray, et al.
Journal of the National Cancer Institute|November 2, 1988
Interim report of phase II study of new nitrosourea S 10036 in disseminated malignant melanomaD Khayat, J P Bizzari, M Frenay, et al.
The American Journal of Clinical Nutrition|March 29, 2001
Occasional physical inactivity combined with a high-fat diet may be important in the development and maintenance of obesity in human subjectsT Y Shepard, K M Weil, T A Sharp, et al.
Epidemiology and Infection|September 15, 2017
Prevalence of anti-hepatitis B surface antibodies among children and adolescents vaccinated in infancy and effect of booster dose administered within a pilot studyR Bassal, M P Markovich, M Weil, et al.
Mutagenesis|May 24, 2008
The effects of Atm haploinsufficiency on mutation rate in the mouse germ line and somatic tissueAkshay K Ahuja, Ruth C Barber, Robert J Hardwick, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Prognosis and treatment of acute lymphoblastic leukemia. Study of 650 patientsC Jacquillat, M Weil, M F Auclerc, et al.
Clinical and Experimental Immunology|February 1, 1994
Follow up of soluble IL-2 receptor level in metastatic malignant melanoma patients treated by chemoimmunotherapyC Soubrane, R Mouawad, M Ichen, et al.
Melanoma Research|December 1, 1995
Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patientsO Rixe, C Borel, D Paraiso, et al.
Pageof 50